Young Seok Cho
Engineering · University of Michigan
Publications
37
Citations
642
Est. group size
~27
Recurring co-author estimate
Active years
42
Publishing since 1985
Typically publishes in teams of ~11 · 0% small-team papers (≤3 authors) · across 6 venues
- An in situ immunogenicity-amplifying payload delivery system for immunotherapy of Kirsten rat sarcoma viral oncogene homolog–mutant cancer
Journal of Controlled Release · 2025
- Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway
Biomaterials · 2024
- Stimulating macropinocytosis of peptide-drug conjugates through DNA-dependent protein kinase inhibition for treating KRAS-mutant cancer
Journal of Controlled Release · 2024
- Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment
Journal of Controlled Release · 2024
- Letter-to-editor, “Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG” [Journal of Controlled Release, Volume 346, pp. 158-168, (2022), doi: 10.1016/j.jconrel.2022.04.012].
Journal of Controlled Release · 2023
- Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC
Journal of Controlled Release · 2022
- Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer
Biomaterials · 2022
- Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer
Journal of Controlled Release · 2022
- Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG
Journal of Controlled Release · 2022
- Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects
Journal of Controlled Release · 2021
- Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer
Biomaterials · 2021
- The novel strategy for concurrent chemoradiotherapy by conjugating the apoptotic cell-binding moiety to caspase-3 activated doxorubicin prodrug
Journal of Controlled Release · 2019
- PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis
Journal of the American College of Cardiology · 2018
- Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer
Biomaterials · 2018
- Self‐Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase‐Cleavable Linker
Advanced Science · 2018
- Journal of Controlled Release×10
- Biomaterials×4
- Regular and Young Investigator Award Abstracts×2
- Zenodo (CERN European Organization for Nuclear Research)×2
- Advanced Drug Delivery Reviews×1
- Hanh Thuy Nguyen
Engineering · Purdue University West Lafayette
- Jiangsheng Xu
Engineering · The Ohio State University
- Ling Mei
Engineering · University of Michigan
- Hongwei Chen
Engineering · University of Michigan
- Peng Zhang
Engineering · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile